O-type foot-and-mouth disease virus polyepitope virus-like particle nanogen and preparation method and application thereof
By expressing type O foot-and-mouth disease virus multi-epitope virus-like particle nanoantigens through CHO cell secretion, using HBc protein as a backbone, tandemly connecting antigenic epitopes, and simplifying the production process, the problems of uncertain immunization effects and high production costs in large animals in existing technologies have been solved, achieving efficient and low-cost industrial production and good immune protection effects.
Patent Information
- Application Number
- CN202510274872.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-03-10
- Publication Date
- 2026-07-24
- Estimated Expiration
- 2045-03-10
AI Technical Summary
Existing foot-and-mouth disease virus multi-epitope virus-like particle vaccines have uncertain efficacy in large animal immunization, high production costs, and complex production processes, making industrialization difficult.
A multi-epitope virus-like particle nanoantigen of type O foot-and-mouth disease virus was designed and expressed through secretion in CHO cells. Using HBc protein as a backbone, multiple antigenic epitopes were tandemly linked, and purification was achieved by sucrose gradient centrifugation, simplifying the production process.
The industrial production of O-type foot-and-mouth disease virus multi-epitope virus-like particle nanoantigens has been achieved with high efficiency and low cost. It has good immunization effect, protects immune animals such as pigs, cattle and sheep against viral attacks, and simplifies the production process.